[Trial chemoprophylaxis of traveler's diarrhea using nifuroxazide]

Pathol Biol (Paris). 1986 Jun;34(5 Pt 2):669-71.
[Article in French]

Abstract

Traveler's diarrhea is a very common condition that affects approximately 12 million subjects each year. This disorder is benign but nevertheless interferes with the traveler's plans in 40% of cases. Several drugs have been used for prophylaxis, in association with appropriate precautions concerning food and drink. Trimethoprim-sulfamethoxazole and cyclines are effective but may induce adverse effects. Nifuroxazide in a dose of 400 mg each day throughout the trip has proved effective. Tolerance was outstanding with no adverse effects.

Publication types

  • English Abstract

MeSH terms

  • Adult
  • Aged
  • Anti-Infective Agents / therapeutic use*
  • Antidiarrheals / therapeutic use*
  • Diarrhea / prevention & control*
  • Egypt
  • Humans
  • Hydroxybenzoates / therapeutic use*
  • Mexico
  • Middle Aged
  • Nitrofurans / therapeutic use*
  • Travel*

Substances

  • Anti-Infective Agents
  • Antidiarrheals
  • Hydroxybenzoates
  • Nitrofurans
  • nifuroxazide